Stigmabase | HIV

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced that ... View article...

Even in the era of effective antiretroviral treatment, wasting syndrome remains a threat for some people living with HIV . View article...

President Mogae led Botswana between 1998 and 2008, tackling Botswana's HIV pandemic with resolve and dedication as the country faced one of highest ... View article...

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV , offering the potential to forego traditional daily ... View article...

The Kennedy family member and congressional candidate is proposing free nationwide access to PrEP and PEP as his cousin, RFK Jr., undoes HIV  ... View article...

Saskatchewan's HIV rate is more than three times the national average, driven largely by intravenous drug use and unprotected sex. View article...

HIV PrEP uptake is suboptimal among commercially-insured adolescents and young adults in the United States. View article...

Now Rockefeller scientists have established the most comprehensive view to date of how HIV -1 can escape bNAbs. Using thousands of parallel viral ... View article...